Board of Directors
Partnerships & Collaborations

ReiThera is a subsidiary of Keires AG, which is a company headquartered in Basel, Switzerland. Keires AG gives guidance through its expert scientific advisory board on the activities performed by ReiThera under a research agreement with GSK.

ReiThera has also obtained grants from the National Institutes of Health (NIH) and the European Union (EU), for the development and early clinical trials of a prophylactic vaccine for hepatitis C.